Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis

Journal of Cellular and Molecular Medicine

Volumn 6, Issue 4, 2002, Pages 583-592

  Clejan, Sanda ^a   Japa, Shenkar ^a   Clemetson, C ^b   Hasabnis, Sanjeev S ^b   David, Odile ^a   Talano, J V ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Tulane Center for Cardiovascular Health   (United States)

Author keywords

Atherosclerosis; Biochemical markers of inflammation; Coronary artery disease syndrome; Histaminemia; Oxidative stress; Risk factors

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ALPHA TOCOPHEROL; ASCORBIC ACID; DRUG DERIVATIVE; HISTAMINE; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; LIPID; PROSTAGLANDIN F2 ALPHA;

AGED; ARTICLE; BLOOD; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED;

AGED; ASCORBIC ACID; CORONARY ARTERIOSCLEROSIS; DINOPROST; F2-ISOPROSTANES; FEMALE; HISTAMINE; HUMANS; INFLAMMATION; INTERLEUKIN-6; ISOPROSTANES; LIPIDS; MALE; MIDDLE AGED; VITAMIN E;

EID: 0037686239     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2002.tb00456.x     Document Type: Article

References (27)

1. Clemetson C.A.B., The key role of histamine in the development of atherosclerosis and coronary heart disease, Medical Hypotheses, 52: 1-8, 1999
2. Chatterjee I.B., Majumder A.K., Nandi B.K., Subramanian N., Synthesis and some major functions of vitamin C in animals, Ann. NY Acad. Sci., 258: 24-47, 1975
3. Clemetson C.A.B., Histamine and ascorbic acid in human blood, 110: 662-668, 1980
4. Gore I., Tanaka Y., Fujinami T., Shirahama T., Endothelial changes produced by ascorbic acid deficiency in guinea pigs, Arch. Pathol., 80: 371-376, 1965
5. Majno G., Palade C.E., Studies on inflammation: The effect of histamine and serotonin on vascular permeability, J. Biophys. Biochem. Cytol. 11: 571-605, 1961
6. Cutforth R.H., Adult scurvy, Lancet, 1: 454-456, 1958
7. Paterson J.C., Some factors in the causation of internal hemorrhages and in the precipitation of coronary thrombi, Can. Med. Assoc. J., 44: 114-120, 1941
8. Johnston C.S., Solomon R.E., Corte C., Vitamin C depletion is associated with alterations in blood histamine in adults, J. Am. Col. Nutr., 15: 586-591, 1996
9. Manson J.E., Stampler M.J., Willett W.C., et al. A prospective study of vitamin C and incidence of coronary artery disease in women, Circulation, 85: 865 (14a), 1992
10. Stenvinkel P., Heimburger F.P., Dicfalusy U., et al., Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure, Kidney International, 55: 1899-1911, 1999
11. Black D., Reilly C.F., Inflammatory mechanisms in atherosclerosis, Inflammation Research, 46: 237-241, 1997
12. Dhariwal K.R., Whashko P.W., Levine M., Determination of dehydroascorbic acid using high performance chromatography with coulometric detection, Anal. Biochem., 189: 18-23, 1990
13. Vuilleumier J.P., Keck E., Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment, J. Micronutrient Anal., 5: 25-34, 1989
14. 2-isoprostanes, Clin. Chem., 47: 1306-1308, 2001
15. Nourooz-Zadeh J., Gas chromatography-mass spectrometry assay for measurement of plasma isoprostanes, Methods Enzymol., 300: 13-7, 1999
16. Bataile R., Klein B., C-reactive protein levels as a direct indicator of Interleukin 6 levels in human in vivo, Arthritis Rheum. 35: 982-984, 1992
17. Frei B., Stocker R, England L., Ames B.N., Ascorbate: the most effective antioxidant in human blood plasma, Adv. Exp. Med. Biol., 264: 155-163, 1990
18. Frei B., England L., Ames B.N., Ascorbate is an outstanding antioxidant in human blood plasma, Proc. Natl. Acad. Sci., U.S.A., 86: 6377-6381, 1989
19. Jialal I., Grundy S.M., Preservation of endogenous antioxidants in LDL by ascorbate but not probucol during oxidative modification, J. Clin. Invest., 87: 597-601, 1991
20. Frei B., Acerbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage, Am. J. Clin. Nutr., 54: 1113-1185, 1991
21. Riemersma R.A., Wood D.A., MacIntyre C.C.A., Elton R.A., Gey K.F., Oliver M.F., Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene, Lancet, 337: 1-5, 1991
22. 2-like compounds are produced in vivo in humans by non-cyclooxygenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. U.S.A., 87: 9383-9387, 1990
23. Comiancini L., Fratta Pasini A., Garbin U., Camapagnola M., Davoli A., Rigoni A., Zenti M.G., Pastorino A.M., LoCascio V., E-selectin plasma concentration is influenced by glycemic control in NIDDM patients: possible role of oxidative stress, Diabetologia, 40: 584-589, 1997
24. Santini S.A., Marra G., Giardina B., Cotroneo P., Mordente A., Martorana G.E., Manto A., Ghirlanda G., Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM, Diabetes, 46: 1853-1858, 1997
25. Yoshida H., Ishikawa T., Nakamura H., Vitamin E/lipid peroxide ratio and susceptibility of LDL to oxidative modification in non-insulin dependent diabetes mellitus, Arterioscler. Thromb. Vasc. Biol. 17: 1438-1446, 1997
26. Jenkins A.J., Klein R.L., Chassereau C.N., Hermayer K.L., Lopes-Virella M.F., LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation, Diabetes, 45: 762-767, 1996
27. Listen T.E., Roberts L.J.I.I., Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer, J. Biol. Chem., 260(24): 13172-13180, 1985